Hookipa announces formation of Scientific Advisory Board
Hookipa Biotech AG announced the formation of its Scientific Advisory Board (SAB). The SAB is chaired by Emeritus Prof. Dr. Paul-Henri Lambert (PhD), former Chief of Vaccine Research and Development for the WHO Global Program for Vaccines and Immunizations.
The members include scientists and industrial experts: Emeritus Prof. Dr. Stanley Plotkin (MD), Prof. Dr. Michael Mach (PhD), Dr. Arnaud Marchant (MD, PhD) and Prof. Dr. Franz Heinz (PhD). The SAB will provide advice to the Company on a broad range of topics related to research, development, manufacturing, quality control, medical, regulatory, and commercial aspects of the Company’s Vaxwave® platform and specific vaccine targets.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Evonik Venture Capital invests in Laxxon - 3D printed tablets with better drug delivery

Ori Biotech raises over $100 million in Series B funding - Innovative cell and gene therapy manufacturing platform
Enzymes open up new avenues in the chemical industry - BASF steps up White Biotechnology operations
Solvay finalizes agreement to buy Fournier Pharma
Benitec Initiates Patent Infringement Lawsuit
PerkinElmer And BioImage Announce Collaboration For Cell-Based Screening Applications
